These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 5005294)

  • 1. Differential action of a streptococcal bacteriocin on mycoplasmas and microbial L-forms.
    Harwick HJ; Montgomerie JZ; Kalamanson GM; Hubert EG; Potter CS; Guze LB
    Infect Immun; 1971 Sep; 4(3):194-8. PubMed ID: 5005294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bacteriocin from Streptococcus faecalis on microbial L-forms.
    Kalmanson GM; Hubert EG; Guze LB
    J Infect Dis; 1970 Mar; 121(3):311-5. PubMed ID: 4984336
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity of methacycline, related tetracyclines, and other antibiotics against various L-forms and their parent bacteria in vitro.
    Hubert EG; Kalmanson GM; Montgomerie JZ; Guze LB
    Antimicrob Agents Chemother; 1972 Oct; 2(4):276-80. PubMed ID: 4670500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial Properties of Bacteriocin Purified from Serratia marcescens and Computerized Assessment of its Interaction with Antigen 43 in Escherichia coli.
    Mousavi SM; Archangi B; Zamani I
    Arch Razi Inst; 2023 Dec; 78(6):1738-1745. PubMed ID: 38828162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyacrylamide gel identification of bacterial L-forms and Mycoplasma species of human origin.
    Theodore TS; Tully JG; Cole RM
    Appl Microbiol; 1971 Feb; 21(2):272-7. PubMed ID: 5544289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
    Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Researches on the production of inhibitory substances by strains of "N. meningitidis" (author's transl)].
    Barbuti S; Montagna MT; Quarto M
    Ann Sclavo; 1979; 21(4):435-47. PubMed ID: 122053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of thallium acetate on the growth of Acholeplasmataceae, Mycoplasmataceae, and some bacteria species].
    Kunze M
    Zentralbl Bakteriol Orig A; 1972 Dec; 222(4):535-9. PubMed ID: 4145172
    [No Abstract]   [Full Text] [Related]  

  • 10. Characteristics of a bacteriocin derived from Streptococcus faecalis var. zymogenes antagonistic to Diplococcus peumoniae.
    Bottone E; Allerhand J; Pisano MA
    Appl Microbiol; 1971 Aug; 22(2):200-4. PubMed ID: 4398532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguti O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
    Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characteristics of a novel bacteriocin produced by Enterococcus faecalis L11 isolated from Chinese traditional fermented cucumber.
    Gao Y; Li B; Li D; Zhang L
    Biotechnol Lett; 2016 May; 38(5):871-6. PubMed ID: 26875092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of a novel bacteriocin produced by Enterococcus faecalis strain RJ-11.
    Yamamoto Y; Togawa Y; Shimosaka M; Okazaki M
    Appl Environ Microbiol; 2003 Oct; 69(10):5746-53. PubMed ID: 14532021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties and characteristics of a bacteriocin from Serratia marcescens.
    Foulds JD; Shemin D
    J Bacteriol; 1969 Sep; 99(3):655-60. PubMed ID: 4905530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin sensitivity.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):226-31. PubMed ID: 4552885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nature of bacteriocins].
    Brandis H
    Naturwissenschaften; 1975 Jan; 62(1):22-8. PubMed ID: 806026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensitivity of L forms and Mycoplasma to various antibiotics].
    Pallanza R
    Boll Chim Farm; 1967 Dec; 106(12):855-60. PubMed ID: 4977938
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of a bacteriocin produced by Streptococcus faecalis var. zymogenes (E1) on susceptible microorganisms.
    Bottone E; Allerhand J; Pisano MA
    Antonie Van Leeuwenhoek; 1974; 40(3):385-92. PubMed ID: 4152856
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotactic activity of L-forms and mycoplasma.
    Harwick HJ; Kalmanson GM; Guze LB
    Aust J Exp Biol Med Sci; 1977 Aug; 55(4):431-4. PubMed ID: 414709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic stability of the antagonistic character of Enterococcus faecalis ssp. liquefaciens and the detection of a new inhibitory bacteriocin-like substance.
    Martínez-Bueno M; Gálvez A; Maqueda M; Valdivia E
    Folia Microbiol (Praha); 1990; 35(2):113-23. PubMed ID: 2116372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.